IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS

耐药性莱姆关节炎自身抗原的鉴定

基本信息

  • 批准号:
    7723039
  • 负责人:
  • 金额:
    $ 0.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-06-01 至 2009-05-31
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Antibiotic treatment-resistant Lyme arthritis is characterized by B-T cell aggregates and plasma cell clusters in synovial tissue from affected joints, after apparent eradication of Borrelia burgdorferi infection. It is suspected that this cellular activity in the joint is a due to activation of self-reactive B cells with subsequent production of autoantibodies. This work focuses on identification of potential self antigenic proteins from synovial tissue. Microdissected plasma cells from affected joints were cultured in vitro and the antibodies were purified from the cell supernates. These potential autoantibodies were conjugated to agarose beads and used to affinity purify antigenic proteins from synovial fluid. Proteins were eluted from the beads and separated by SDS-PAGE. Protein bands were excised from gels and subjected to in-gel trypsin digestion. Peptides extracted from the in-gel digests were analyzed by MALDI-TOF mass spectrometry for protein identification. We have identified a cytokeratin that was present in one sample, but not in control blank gel slices. We have confirmed the finding by Western blot and continue to search for other proteins in additional samples. A manuscript describing our results has recently been published.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brigitte T. Huber其他文献

Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules
细菌和内源性逆转录病毒超抗原的结合位点可以在主要组织相容性复合物 II 类分子上解离
  • DOI:
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    15.3
  • 作者:
    Jacques Thibodeau;Nathalie Labrecque;François Denis;Brigitte T. Huber;Rafick
  • 通讯作者:
    Rafick
Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice
Mls 基因与近交系小鼠内源性乳腺肿瘤病毒的连锁
  • DOI:
    10.1038/349526a0
  • 发表时间:
    1991-02-07
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Wayne N. Frankel;Christine Rudy;John M. Coffin;Brigitte T. Huber
  • 通讯作者:
    Brigitte T. Huber
Molecular characterization of Mls-1.
Mls-1 的分子表征。
Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles.
II 类 MHC 产物和 Tcrb-V8.2 等位基因控制大鼠 T 细胞对逆转录病毒和细菌超抗原的反应。
  • DOI:
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Thomas Herrmann;T. Hochgrebe;N. Torres;Brigitte T. Huber;T. Hünig
  • 通讯作者:
    T. Hünig
Localization of spontaneously hyperactive B cells of NZB mice to a specific B cell subset.
NZB 小鼠自发性过度活跃 B 细胞定位于特定 B 细胞亚群。

Brigitte T. Huber的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brigitte T. Huber', 18)}}的其他基金

IDENTIFICATION OF DPP2 SUBSTRATE IN THE VMN OF THE HYPOTHALAMUS
下丘脑 VMN 中 DPP2 底物的鉴定
  • 批准号:
    8365792
  • 财政年份:
    2011
  • 资助金额:
    $ 0.52万
  • 项目类别:
IDENTIFICATION OF DPP2 SUBSTRATE IN THE VMN OF THE HYPOTHALAMUS
下丘脑 VMN 中 DPP2 底物的鉴定
  • 批准号:
    8171443
  • 财政年份:
    2010
  • 资助金额:
    $ 0.52万
  • 项目类别:
TARGETS FOR AUTOANTIBODIES FROM SYNOVIAL LESIONS IN CHRONIC LYME ARTHRITIS
慢性莱姆关节炎滑膜病变自身抗体的靶点
  • 批准号:
    7723069
  • 财政年份:
    2008
  • 资助金额:
    $ 0.52万
  • 项目类别:
HERV-K18 as a Risk Factor for CFIDS
HERV-K18 作为 CFIDS 的风险因素
  • 批准号:
    7366904
  • 财政年份:
    2007
  • 资助金额:
    $ 0.52万
  • 项目类别:
HERV-K18 as a Risk Factor for CFIDS
HERV-K18 作为 CFIDS 的风险因素
  • 批准号:
    7924814
  • 财政年份:
    2007
  • 资助金额:
    $ 0.52万
  • 项目类别:
TARGETS FOR AUTOANTIBODIES FROM SYNOVIAL LESIONS IN CHRONIC LYME ARTHRITIS
慢性莱姆关节炎滑膜病变自身抗体的靶点
  • 批准号:
    7602063
  • 财政年份:
    2007
  • 资助金额:
    $ 0.52万
  • 项目类别:
HERV-K18 as a Risk Factor for CFIDS
HERV-K18 作为 CFIDS 的风险因素
  • 批准号:
    8132466
  • 财政年份:
    2007
  • 资助金额:
    $ 0.52万
  • 项目类别:
IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS
耐药性莱姆关节炎自身抗原的鉴定
  • 批准号:
    7602033
  • 财政年份:
    2007
  • 资助金额:
    $ 0.52万
  • 项目类别:
HERV-K18 as a Risk Factor for CFIDS
HERV-K18 作为 CFIDS 的风险因素
  • 批准号:
    7674657
  • 财政年份:
    2007
  • 资助金额:
    $ 0.52万
  • 项目类别:
HERV-K18 as a Risk Factor for CFIDS
HERV-K18 作为 CFIDS 的风险因素
  • 批准号:
    7500307
  • 财政年份:
    2007
  • 资助金额:
    $ 0.52万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 0.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 0.52万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 0.52万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 0.52万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 0.52万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 0.52万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 0.52万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 0.52万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 0.52万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 0.52万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了